Một trường hợp bệnh lý thận đa nang tự động ưu thế với sự cải thiện nhiễm trùng nang khó điều trị sau khi kéo dài thời gian thẩm tách máu

Sallee M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4:1183–9. Ryu H, Kim H, Park HC, Kim H, Cho EJ, Lee K, Chung W, Oh K, Cho JY, Hwang Y, Ahn C. Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2017;18:22. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35:469–76. Menon V, Rudym D, Chandra P, Miskulin D, Perrone R, Sarnak M. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin J Am Soc Nephrol. 2011;6:7–13. Charra B, Calemard E, Ruffet M, Chazot C, Terrat J, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int. 1992;41:1286–91. Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC. Conference Participants. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2015;88:17–27. Lantinga MA, Casteleijn NF, Geudens A, de Sévaux RG, van Assen S, Leliveld AM, Gansevoort RT, Drenth JP. Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review. Nephrol Dial Transpl. 2017;32:144–50. Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012;22:149–56. Cohen G, Hörl WH. Immune dysfunction in uremia—an update. Toxins. 2012;4:962–90. Scribner BH, Oreopoulos DG. The hemodialysis product (HDP): a better index of dialysis adequacy than Kt/V. Dial Transpl. 2002;31:13–5. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 1985;28:526–34. Jofré R, Rodriguez-Benitez P, López-Gómez JM, Pérez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006;17(suppl 3):S274–80. Shah N, Parikh V, Patel N, Patel N, Badheka A, Deshmukh A, Rathod A, Lafferty J. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III. Int J Cardiol. 2014;171:390–7. Rogers C. Postgastrectomy nutrition. Nutr Clin Pract. 2011;26:126–36. Shinzato T, Nakai S, Miwa M, Iwayama N, Takai I, Matsumoto Y, Morita H, Maeda K. New method to calculate creatinine generation rate using pre- and postdialysis creatinine concentrations. Artif Organs. 1997;21:864–72. Kalantar-Zadeh K, Kopple JD. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis. 2001;38:1343–50. Matsumoto Y, Furuta A, Furuta S, Miyajima M, Sugino T, Nagata K, Sawada S. The impact of pre-dialytic endurance training on nutritional status and quality of life in stable hemodialysis patients (Sawada Study). Ren Fail. 2007;29:587–93. Kaizu Y, Ohkawa S, Kumagai H. Muscle mass index in haemodialysis patients: a comparison of indices obtained by routine clinical examinations. Nephrol Dial Transpl. 2002;17:442–8. Park J, Ahmadi SF, Streja E, Molnar MZ, Flegal KM, Gillen D, Kovesdy CP, Kalantar-Zadeh K. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis. 2014;56:415–25. Kakiya R, Shoji T, Tsujimoto Y, Tatsumi N, Hatsuda S, Shinohara K, Kimoto E, Tahara H, Koyama H, Emoto M, Ishimura E, Miki T, Tabata T, Nishizawa Y. Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int. 2006;70:549–56.